Opus Genetics, Inc. · NASDAQ:IRD
Perceptive Advisors LLC reported a 9.99% stake in Opus Genetics, Inc. (Schedule 13G/A)
Event Sep 30, 2026 · Filed Nov 16, 2026
Perceptive Advisors LLC reported a 9.99% stake in Opus Genetics, Inc., 10,086,525 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 10,086,525
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 9.99% | 10,086,525 |
| Joseph Edelman | 9.99% | 10,086,525 |
| Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 10,086,525 |
Source
Download original · View original at SEC
Related
- Opus Genetics, Inc.
- Perceptive Advisors LLC
- Opus Genetics, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · May 15, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026
- Schedule 13G · Perceptive Advisors LLC · Mar 31, 2025
- Schedule 13G · Boxer Capital Management, LLC · Nov 16, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Nov 16, 2026
- Schedule 13G · Cormorant Asset Management, LP · Nov 16, 2026
- Schedule 13G/A · Caligan Partners LP · Nov 16, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Nov 12, 2026